Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials | World Journal of Surgical Oncology | Full Text
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
Myeloid Growth Factor Support for Dose-Dense Adjuvant Chemotherapy for Breast Cancer
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials - The Lancet
Comparative hematological profiles for dose‑dense vs. regular anthracycline‑based neoadjuvant chemotherapy in non‑metastatic breast cancer
Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients | PLOS ONE
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients | Semantic Scholar
Assessing the impact of CMF-like/Anthracycline-based/Anthracycline-Taxane-based/dose-dense chemotherapy in dependency of positive axillary lymph nodes/hormone receptor-status/grading/T-stage on survival – A retrospective multi-centre cohort study of ...
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Dose-dense chemotherapy in breast cancer and lymphoma - ScienceDirect
Dr Sunil Verma on Twitter: "Dr. Gray sharing data on chemotherapy schedule impact on breast cancer outcome - overall improved outcome with dose dense approach #SABCS17 https://t.co/1TvnDXVFpu" / Twitter
Current status of dose-dense chemotherapy for breast cancer | SpringerLink
![PDF] The dose-dense principle in chemotherapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6c36a4f67d16b6fd3b91bd33f3bf6afc52785061/4-Figure3-1.png "PDF] The dose-dense principle in chemotherapy. | Semantic Scholar")
PDF] The dose-dense principle in chemotherapy. | Semantic Scholar
Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes? - Annals of Oncology
Dose-dense paclitaxel plus carboplatin <i>vs</i>. epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancer
Dose-Dense Docetaxel versus Weekly Paclitaxel following Dose-Dense Epirubicin and Cyclophosphamide as Adjuvant Chemotherapy in Node-Positive Breast Cancer Patients: A Retrospective Cohort Analysis
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer | HTML
Standard vs dose-dense adjuvant chemotherapy in hormone... | Download Scientific Diagram
Current status of dose-dense chemotherapy for breast cancer | SpringerLink
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Dose-dense Chemotherapy for Aggressive Non-Hodgkin Lymphoma
Novel Systemic Treatments in High Grade Ovarian Cancer | IntechOpen
